Professor Cash wrote to Dr Archie McIntyre re NANB (Chiron) testing, noting his anticipation that a decision whether to introduce such testing throughout UKBTS would be made in October 1989. Read more about Professor Cash wrote to Dr Archie McIntyre re NANB (Chiron) testing, noting his anticipation that a decision whether to introduce such testing throughout UKBTS would be made in October 1989.
Professor Cash wrote to colleagues by way of update, indicating NANB (Chiron) Testing soon. Read more about Professor Cash wrote to colleagues by way of update, indicating NANB (Chiron) Testing soon.
Professor Cash wrote to Dr Gunson in relation to the Chiron Test, stating their Service would not move unilaterally unless instructed to do so by SHHD, and he noted that SNBTS would only be able to discuss contracts for supply (of the HCV test) when instructed to do so. Read more about Professor Cash wrote to Dr Gunson in relation to the Chiron Test, stating their Service would not move unilaterally unless instructed to do so by SHHD, and he noted that SNBTS would only be able to discuss contracts for supply (of the HCV test) when instructed to do so.
Marcela Contreras wrote to Dr Gunson in relation to factors to consider before placing orders for routine donor screening with the new anti-HCV test, including whether "lookback" would be required, the expense of obtaining and processing confirmatory samples and the data from the preliminary studies in Europe requiring extension. Read more about Marcela Contreras wrote to Dr Gunson in relation to factors to consider before placing orders for routine donor screening with the new anti-HCV test, including whether "lookback" would be required, the expense of obtaining and processing confirmatory samples and the data from the preliminary studies in Europe requiring extension.
Dr Lloyd, NBTS, wrote to Mr Garland, director of management services of the Northern Regional Health Authority in relation to non-A non-B Hepatitis, noting the fairly rapid mounting pressure for the test to be introduced in the UK, likely without funding by the Department. Read more about Dr Lloyd, NBTS, wrote to Mr Garland, director of management services of the Northern Regional Health Authority in relation to non-A non-B Hepatitis, noting the fairly rapid mounting pressure for the test to be introduced in the UK, likely without funding by the Department.
Professor Cash wrote to Dr Gunson, stating it was important for the SNBTS to look at the prevalence of the Chiron test positives in the donor community, noting 5000 donations were to be selected from those with ALT data already identified. Read more about Professor Cash wrote to Dr Gunson, stating it was important for the SNBTS to look at the prevalence of the Chiron test positives in the donor community, noting 5000 donations were to be selected from those with ALT data already identified.
Dr Lane sent Dr Rejman a paper for discussion at the next ACVSB meeting which concluded that the procedures to minimise hepatitis virus transmissions continued to present problems, giving rise to a need to address the requirements for a marker to identify non-A non-B Hepatitis (HCV) carrier status. Read more about Dr Lane sent Dr Rejman a paper for discussion at the next ACVSB meeting which concluded that the procedures to minimise hepatitis virus transmissions continued to present problems, giving rise to a need to address the requirements for a marker to identify non-A non-B Hepatitis (HCV) carrier status.
At a meeting of the North London Blood Transfusion Centre, discussions included results of the US studies, significance of positive anti-HCV test results, equipment and kits, and options to have positive/borderline samples sent for further testing. Read more about At a meeting of the North London Blood Transfusion Centre, discussions included results of the US studies, significance of positive anti-HCV test results, equipment and kits, and options to have positive/borderline samples sent for further testing.
Dr Marcela Contreras, director of North London Blood Transfusion Centre, wrote to Dr Gunson regarding funding for the introduction of anti-HCV screening of blood donations in 1990 and admitted that she did not consider anti-HCV testing to be a top priority. Read more about Dr Marcela Contreras, director of North London Blood Transfusion Centre, wrote to Dr Gunson regarding funding for the introduction of anti-HCV screening of blood donations in 1990 and admitted that she did not consider anti-HCV testing to be a top priority.
Marcela Contreras and John Barbara wrote to Dr Harvey Alter, stating it was unethical to delay anti-HCV screening pending the US study of post-transfusion hepatitis infections, and questioned the causal association between transfusion and cases of cirrhosis. Read more about Marcela Contreras and John Barbara wrote to Dr Harvey Alter, stating it was unethical to delay anti-HCV screening pending the US study of post-transfusion hepatitis infections, and questioned the causal association between transfusion and cases of cirrhosis.